LEADER 04185nam 2201237z- 450 001 9910580206103321 005 20220706 035 $a(CKB)5690000000012027 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/87524 035 $a(oapen)doab87524 035 $a(EXLCZ)995690000000012027 100 $a20202207d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aPredicting Psychopathological Onset: Early Signs of Neuropsychiatric Diseases 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (242 p.) 311 08$a3-0365-4542-5 311 08$a3-0365-4541-7 330 $aThe aim of this Special Issue is to collect valuable contributions from scientists worldwide working on the role that biological, behavioral, and cognitive markers can have in predicting the onset of neuropsychiatric disorders. We were able to collect 13 original articles and two reviews on this topic. The results published in this Special Issue could provide significant support in pre-clinical phases for the identification of vulnerability factors, to better understand the course of the illness, and to predict its outcome, as well as aiding clinicians in the therapeutic decision-making process. 517 $aPredicting Psychopathological Onset 606 $aMedicine and Nursing$2bicssc 606 $aPharmacology$2bicssc 610 $aadolescence 610 $aaffective disorder 610 $aaffective temperaments 610 $aaging 610 $aalexithymia 610 $aassessment 610 $aattachment 610 $aAttentional Boost Effect 610 $aAutism Spectrum Disorders (ASD) 610 $abipolar disorder 610 $abipolar disorders 610 $abody image 610 $acerebellum 610 $achildhood apraxia of speech 610 $achildren 610 $aclassification 610 $acognitive decline 610 $aCOVID-19 610 $aCOVID-19 vaccine 610 $acriminal behaviour 610 $adepression 610 $adepressive disorders 610 $adiadochokinesia 610 $aemotional dysregulation 610 $aemotional eating 610 $aemotional regulation 610 $aepidemiological survey 610 $aeuthymic patients 610 $aexercise addiction 610 $afatherhood 610 $aforgetting 610 $aFreeSurfer 610 $afrequency data 610 $afriend and family interview 610 $agambling disorder 610 $agender 610 $agenetic variants 610 $aheart rate variability 610 $ahigh-risk group 610 $aintegration 610 $aMagnetic Resonance Imaging (MRI) 610 $amentalization 610 $amicrobiota 610 $amotor control 610 $amultilevel model 610 $amultiple risk factors 610 $an/a 610 $aneuroanatomy 610 $aneurotransmitter system 610 $aneurovisceral integration model 610 $anomogram 610 $apatient health questionnaire 610 $aperinatal period 610 $apolyvagal theory 610 $aprefrontal functions 610 $aprevention 610 $apsychiatric disorders 610 $apsychological distress 610 $apsychopathologies 610 $apsychopathology 610 $arecognition memory 610 $ascreening 610 $aself-esteem 610 $aself-report measure 610 $asensory motor performance 610 $asocial isolation 610 $atime perception 610 $aTMAU 610 $avaccine acceptance 610 $avaccine intention 610 $ayoung adults 610 $ayouth 615 7$aMedicine and Nursing 615 7$aPharmacology 700 $aCostanzi$b Marco$4edt$01279063 702 $aCostanzi$b Marco$4oth 906 $aBOOK 912 $a9910580206103321 996 $aPredicting Psychopathological Onset: Early Signs of Neuropsychiatric Diseases$93014503 997 $aUNINA